Vaccini, Sicily pins Astrazeneca under 60: ‘Second doses confirmed’

He stopped, but only for now, the AstraZeneca/Vaxzevira vaccine in less than 60 years. The Sicily region decided, as a precaution, to send a letter to the directors general of health agencies and to the Covid commissioners on an island. “In light of recent press reports regarding the positions taken by the Chairman of the Scientific Technical Committee – we read – in reference to the balance of risks/benefits regarding the administration of Vaxzevria vaccine (formerly Astrazeneca ed) to persons under the age of sixty, and pending an official decision by the same body, The suspension is immediately arranged by the administration for all citizens under the age of sixty as a precautionary measure.”

Stop would not be valid for those waiting for the second dose, says Daose’s general manager, Mario LaRocca, “in the absence of opposing scientific evidence.” However, in Sicily, open days scheduled from today until Sunday remain scheduled, but the only vaccine that will be administered will be the Johnson & Johnson vaccine.

Today, the Gimbe Foundation filed the case, which argued that in the event of low circulation of the Covid virus, it is best to allocate the AstraZeneca and Johnson & Johnson vaccine to more than 50, so that the risks of vaccines to virus carriers are as low as possible. This position was taken after the (rare) adverse effects associated with the AstraZeneca vaccine appeared among the very young, which were intended for open days.